TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of People With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens.

Mariya Huralska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.